It remains a mysterious problem with enormous economic and management complications. There are no known causes or treatments for SIB. Recent evidence has implicated the endogenous opiate system, specifically B- endorphin (BE), in this aberrant behavior. The most compelling evidence supporting the opiate hypothesis is that challenge with opiate blockers decreased SIB in mentally retarded patients. In the first direct test of the opiate hypothesis, blood levels of BE, but not related peptides, were elevated immediately after an SIB episode. Most significantly, patients with the largest change in BE after SIB were the most positive responders to opiate blockers. The major objective of the proposed project is to replicate and extend these new observations, to determine if BE is a specific biological marker for forms of SIB and determine if changes in BE after SIB predict response to treatment. The primary hypothesis is that SIB results from disturbance of the opiate system manifested by, 1) unique and specific release of BE after SIB and, 2) sensitivity of the opiate receptor to opiate blockers. This hypothesis will be tested in sixty four mentally-retarded clients (n=16/group) with SIB or agitated behavior (AB) in a five phase study. Candidate clients will be identified and characterized by intensive behavioral observation in the first two phases. During the third phase, blood will be collected immediately after SIB or AB and analyzed for BE and the related peptides, ACTH and CRH. In phase four, response of clients will be evaluated to acute challenge with three doses of an opiate blocker, naltrexone (NTX). Response to long-term challenge (nine to twenty-one months) with NTX will comprise phase five. Results will be analyzed to; 1) determine the relationship between BE release after SIB and response to NTX and, 2) determine the unique contribution of BE to SIB.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD031571-03
Application #
2025538
Study Section
Human Development and Aging Subcommittee 3 (HUD)
Project Start
1995-01-01
Project End
1998-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Psychiatry
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Sandman, Curt A; Touchette, Paul E; Marion, Sarah D et al. (2008) The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Dev Psychobiol 50:680-9
Kemp, Aaron S; Fillmore, Paul T; Lenjavi, Mohammed R et al. (2008) Temporal patterns of self-injurious behavior correlate with stress hormone levels in the developmentally disabled. Psychiatry Res 157:181-9
Crockett, Carolyn M; Sackett, Gene P; Sandman, Curt A et al. (2007) Beta-endorphin levels in longtailed and pigtailed macaques vary by abnormal behavior rating and sex. Peptides 28:1987-97
Marion, Sarah DeBoard; Touchette, Paul E; Sandman, Curt A (2003) Sequential analysis reveals a unique structure for self-injurious behavior. Am J Ment Retard 108:301-13
Sandman, Curt A; Touchette, Paul; Lenjavi, Mohammed et al. (2003) beta-Endorphin and ACTH are dissociated after self-injury in adults with developmental disabilities. Am J Ment Retard 108:414-24
Sandman, Curt A; Touchette, Paul; Marion, Sarah et al. (2002) Disregulation of proopiomelanocortin and contagious maladaptive behavior. Regul Pept 108:179-85
Sandman, C A; Hetrick, W; Talyor, D et al. (2000) Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury. Peptides 21:785-91
Sandman, C A; Hetrick, W; Taylor, D V et al. (2000) Long-term effects of naltrexone on self-injurious behavior. Am J Ment Retard 105:103-17
Sandman, C A; Hetrick, W; Taylor, D V et al. (1997) Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. Am J Ment Retard 102:182-99